Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions

US Patent 11066361 · Granted Jul 20, 2021

Assignee

Inventors

View full patent text on Google Patents →